AI Visibility Scorecard
dojolvi.com · Healthcare
Borderline visible. AI bots can crawl DOJOLVI® (triheptanoin) for LC, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 11 times
Claude · Meta AI · ChatGPT · Apple Intelligence
#43,742 of 925,367 in Healthcare for AI visibility
27
AI Naming Predictability
iRarely named · 27/100
Healthcare average 11
Top 10% of Healthcare
See what's behind this score →4.3
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →30
Muse Index Score
iAI agent readiness
Basic · 30/100
Healthcare average 18
See what's behind this score →0
from our crawl and measurement
DOJOLVI® (triheptanoin) for LC describes itself simply: "DOJOLVI® (triheptanoin) is the first and only FDA-approved treatment for patients diagnosed with long-chain fatty acid oxidation disorders (LC-FAOD)." When AI engines look at it, they find little to work with. It scores 4.3 out of 10.
The site does the on-page work well, with structured data on the page (WebPage, BreadcrumbList, WebSite), an llms.txt file for AI models, a sitemap.
Our monitoring has logged 2 AI crawler visits here: the engines come, the question is what they find.
Strong · Good · Fair · Weak
Structured Data
Fair
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Strong
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 4.3/10, DOJOLVI® (triheptanoin) for LC is crawlable but under-signaled - fixable, and the signals above are where to start.
WHAT IS DOJOLVI?
DOJOLVI is a prescription medicine used to treat long-chain fatty acid oxidation disorders (LC-FAOD) in children and adults.
WHAT ARE LC-FAOD?
Long-chain fatty acid oxidation disorders (LC-FAOD) are rare inherited disorders that prevent the body from breaking down long-chain fatty acids into energy during metabolism.
Are you a US resident?
The information on DOJOLVI.com is intended for US residents. Please confirm below. No Yes
Is this your brand?
The exact fixes for DOJOLVI® (triheptanoin) for LC
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
When a buyer asks ChatGPT which company to use, two different things can happen. ChatGPT can name a company in its answer. Or it can link to a web page as a source. Most advice about AI visibility is about the second one. Our data says the first one is what matters.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for DOJOLVI® (triheptanoin) for LC.
Scored by Engagemii on August 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/dojolvi
Cite this score: Engagemii (2026). "AEO Score for DOJOLVI® (triheptanoin) for LC." Retrieved from https://engagemii.com/aeo/brands/dojolvi
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform